Omni Partners’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,446,247
Closed -$1.24K 79
2019
Q4
$1.24K Buy
+1,446,247
New +$1.11M 0.03% 38

Omni Partners's GCVRZ Position: Q1 2020 in Review

Omni Partners sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 1,446,247 shares — an estimated $1.24K sold.

Omni Partners first reported a position in GCVRZ in Q4 2019 and held it in 1 quarter. The position peaked at $1.24K in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

  • Omni Partners reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
  • Omni Partners sold 1,446,247 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $1.24K.
  • Omni Partners first reported a position in Sanofi Contingent Value Rights in Q4 2019 and held it in 1 quarter.
  • Omni Partners's Sanofi Contingent Value Rights position peaked at $1.24K in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Omni Partners's 13F filing for Q1 2020, filed 15 May 2020.